1. Shimizu, Hiromitsu, Iwayama, Yoshimi, Yamada, Kazuo, Osumi, Noriko, Yoshikawa, Takeo. 2006. Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia. In Schizophrenia research, 84, 244-52. doi:. https://pubmed.ncbi.nlm.nih.gov/16624526/
2. Lin, Hao, Wu, Tingrui, Peng, Lijiao, Huang, Jing, Wei, Bo. 2020. Lnc-MAP6-1:3 knockdown inhibits osteosarcoma progression by modulating Bax/Bcl-2 and Wnt/β-catenin pathways. In International journal of medical sciences, 17, 2248-2256. doi:10.7150/ijms.47405. https://pubmed.ncbi.nlm.nih.gov/32922188/
3. Schwenk, Benjamin M, Lang, Christina M, Hogl, Sebastian, Haass, Christian, Edbauer, Dieter. 2013. The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes. In The EMBO journal, 33, 450-67. doi:10.1002/embj.201385857. https://pubmed.ncbi.nlm.nih.gov/24357581/
4. Percelay, Solenn, Freret, Thomas, Turnbull, Nicole, Bouet, Valentine, Boulouard, Michel. 2021. Combination of MAP6 deficit, maternal separation and MK801 in female mice: A 3-hit animal model of neurodevelopmental disorder with cognitive deficits. In Behavioural brain research, 413, 113473. doi:10.1016/j.bbr.2021.113473. https://pubmed.ncbi.nlm.nih.gov/34280461/
5. Sébastien, Muriel, Giannesini, Benoit, Aubin, Perrine, Fauré, Julien, Marty, Isabelle. 2018. Deletion of the microtubule-associated protein 6 (MAP6) results in skeletal muscle dysfunction. In Skeletal muscle, 8, 30. doi:10.1186/s13395-018-0176-8. https://pubmed.ncbi.nlm.nih.gov/30231928/
6. Yu, Xin, Guo, Xiaoyu, Li, Wenge, Li, Juanjuan. 2024. A centrosome-related gene signature for predicting the overall survival of uveal melanoma. In Translational cancer research, 13, 771-781. doi:10.21037/tcr-23-1486. https://pubmed.ncbi.nlm.nih.gov/38482432/
智鼠故事 
